Drugs & Targets American Cancer Society study shows need to better identify who may not benefit from aggressive treatment April 12, 2019Vol.45 No.15
Drugs & TargetsFree Varian ARIA Oncology Information System awarded CancerLinQ certification April 05, 2019Vol.45 No.14
Drugs & TargetsFree FDA expands use of metastatic breast cancer treatment to include male patients April 05, 2019Vol.45 No.14
Drugs & TargetsFree FDA issues warning letter to genomics lab for marketing genetic test that claims to predict patients’ responses to specific medications April 05, 2019Vol.45 No.14
Drugs & TargetsFree Nanobiotix receives European approval for Hensify therapy for sarcoma April 05, 2019Vol.45 No.14
Drugs & TargetsFree Findings from ASCO TAPUR trial presented at AACR meeting April 05, 2019Vol.45 No.14
Drugs & Targets FDA advances policy changes to modernize mammography services March 29, 2019Vol.45 No.13
Drugs & Targets FDA issues alert on the investigational use of Venclexta in multiple myeloma March 29, 2019Vol.45 No.13
Drugs & Targets Janssen submits application for Darzalex combination in multiple myeloma March 29, 2019Vol.45 No.13
